{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-036794","form_type":"8-K","ticker":"CTMX","cik":"0001501989","company_name":"CytomX Therapeutics, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.813451+00:00","generated_at":"2026-05-26T03:30:55.899155+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"CytomX receives Nasdaq delisting notice for bid price non-compliance","bullets":["Nasdaq notified CytomX on Feb 24, 2025 that common stock bid price stayed below $1.00 for 30 consecutive business days through Feb 21, 2025.","Company has 180 calendar days, until August 25, 2025, to regain compliance by closing at $1.00 for 10 consecutive business days.","If not cured by the deadline, CytomX may transfer to Nasdaq Capital Market for an additional 180-day compliance period.","Company will monitor bid price and consider options, but there is no assurance of regaining compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-036794","json":"https://secwatch.observer/filing/0001193125-25-036794.json","markdown":"https://secwatch.observer/filing/0001193125-25-036794.md","text":"https://secwatch.observer/filing/0001193125-25-036794.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/0001193125-25-036794-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1501989/000119312525036794/d891467d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:30:55.899155+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}